Copy to clipboard 
Stryker completed the previously announced sale of its U.S. spinal implants business to Viscogliosi Brothers, which has formed a standalone company named VB Spine.
The agreement includes a binding offer to acquire Stryker’s spinal implant business in France. Certain international markets are expected to transfer to VB Spine at later dates.
VB Spine will have exclusive access to Mako Spine and Copilot enabling technologies for use with its implants in spine procedures.
ORTHOWORLD estimates that Stryker’s global spine implant sales accounted for $700 million of its $11.2 billion in 2024 revenue.
Mike Evers, ORTHOWORLD’s Senior Market Analyst, noted that Stryker’s decision to part ways with its spine implant business hardly qualifies as a surprise. After Stryker’s difficult integration of K2M, the company’s spine business managed a CAGR of just 1.4% since 2019. Recent market consolidation made Stryker a distant third player behind Medtronic and Globus Medical with a spinal implant business that couldn’t match the innovation cadence of its competitors.
The divestiture makes sense for Stryker, which has seen a relative lack of synergy between spine and orthopedic franchises. Stryker can now reallocate its focus and resources into higher-growth areas.
“The sale of our spinal implants business enhances our strategic focus, positioning us to meet evolving customer needs and invest where we see the greatest opportunity for innovation and long-term growth,” said Kevin Lobo, Stryker Chair and CEO. “We remain committed to the spine space through our Interventional Spine, Neurotechnology and Enabling Technologies businesses, as well as our strategic partnership with VB Spine. We’re grateful to our Spine team members for their contributions and confident they’re well positioned for continued success.”
The Viscogliosi Brothers have led multiple business transformations in spine, including Spine Solutions, Spine Next, Paradigm Spine, Simplify Medical, Centinel Spine, Companion Spine, Spine BioPharma and Woven Orthopedic Technologies.
“We are honored to work alongside such a talented team and are confident that, with its strong commitment to innovation, surgeon collaboration and commercial execution, VB Spine is uniquely positioned to improve patient outcomes and drive transformation in spine surgery,” said Marc, John and Anthony Viscogliosi, Co-CEOs of VB Spine.
